Výsledky vyhledávání

Akademický článek

Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximab.

Autor: Williams JH; Pfizer Inc., San Diego, California, USA., Hutmacher MM; Ann Arbor Pharmacometrics Group, Ann Arbor, Michigan, USA., Zierhut ML; Pfizer Inc., San Diego, California, USA., Becker JC; Pfizer Inc., New York, New York, USA., Gumbiner B; Pfizer Inc., San Diego, California, USA., Spencer-Green G; Pfizer Inc., Cambridge, Massachusetts, USA., Melia LA; Pfizer Inc., San Diego, California, USA., Liao KH; Pfizer Inc., San Diego, California, USA., Suster M; Pfizer Inc., San Diego, California, USA., Yin D; Pfizer Inc., San Diego, California, USA., Li R; Pfizer Inc., Cambridge, Massachusetts, USA., Meng X; Pfizer Inc., San Diego, California, USA.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 Dec; Vol. 82 (6), pp. 1568-1579. Date of Electronic Publication: 2016 Sep 22.

Zobrazit plný text záznamu

Akademický článek

A phase I pharmacokinetics trial comparing PF-05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis.

Autor: Cohen S; Metroplex Clinical Research Center, Dallas, TX, USA., Emery P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, LS7 4SA, UK.; NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Greenwald M; Desert Medical Advances, Rancho Mirage, CA, USA., Yin D; Pfizer Inc, San Diego, CA, USA., Becker JC; Pfizer Inc, New York, NY, USA., Melia LA; Pfizer Inc, San Diego, CA, USA., Li R; Pfizer Inc, Cambridge, MA, USA., Gumbiner B; Pfizer Inc, San Diego, CA, USA., Thomas D; Pfizer Inc, New York, NY, USA., Spencer-Green G; Pfizer Inc, Cambridge, MA, USA., Meng X; Pfizer Inc, San Diego, CA, USA.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 Jul; Vol. 82 (1), pp. 129-38. Date of Electronic Publication: 2016 Apr 29.

Zobrazit plný text záznamu

Akademický článek

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences.

Autor: Saffari, Fatemeh¹, Jafarzadeh, Abdollah^1,2 jafarzadeh14@yahoo.com

Publikováno v: Indian Journal of Medical Research. Mar/Apr2022, Vol. 155 Issue 3/4, p335-346. 12p.

Zobrazit plný text záznamu

Periodical

Parisian nights.

Autor: Harbi, Michelle

Publikováno v: Business Traveller (UK/Europe Edition). Apr2015, p42-44. 3p.

Zobrazit plný text záznamu

Akademický článek

Survey of Data Package and Sample Size of Comparative Clinical Studies for Biosimilar Developments from PMDA Assessments.

Autor: Kuribayashi R; Office of Cellular and Tissue-Based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan. kuribayashi-ryosuke@pmda.go.jp.; Office of Regulatory Science Research, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan. kuribayashi-ryosuke@pmda.go.jp., Hariu A; Office of Cellular and Tissue-Based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan., Nakano A; Office of Cellular and Tissue-Based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan., Kishioka Y; Office of Cellular and Tissue-Based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan.

Publikováno v: Pharmaceutical medicine [Pharmaceut Med] 2024 May; Vol. 38 (3), pp. 225-239. Date of Electronic Publication: 2024 Apr 29.

Zobrazit plný text záznamu